We are live on
!
Find out more
AIP
Almanack Investment Partners Portfolio holdings
AUM
$785M
1-Year Est. Return
34.37%
This Fund
S&P 500
This Quarter
Est. Return
+15.45%
1 Year Est. Return
+34.37%
3 Year Est. Return
+77.84%
5 Year Est. Return
+81.17%
10 Year Est. Return
–
AUM
$785M
AUM Growth
+$192M
(+32%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
20.08%
Top 10 Holdings %
Top 10 Hldgs %
51.64%
Holding
348
New
171
Increased
90
Reduced
37
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAI
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$14M |
| 2 |
GRID
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
|
+$13.3M |
| 3 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
+$8.22M |
| 4 |
Gadsden Dynamic Multi-Asset ETF
GDMA
|
+$6.6M |
| 5 |
NVIDIA
NVDA
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$12.3M |
| 2 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$10.2M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$9.82M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$8.24M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$7.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.14% |
| 2 | Communication Services | 7.84% |
| 3 | Energy | 2.44% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Healthcare | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
AGNC Investment
AGNC
$12.9B
| $176K | 0.02% |
16,175
+528
| +3% | +$5.56K |
|
302
Aurora
AUR
$13.8B
| $176K | 0.02% |
+25,750
| New | +$158K |
|
303
Regenxbio
RGNX
$708M
| $167K | 0.02% |
+13,955
| New | +$116K |
|
304
VanEck Bitcoin Trust
HODL
$1.08B
| $167K | 0.02% |
10,034
-326
| -3% | -$6.62K |
|
305
Precision BioSciences
DTIL
$207M
| $161K | 0.02% |
+20,428
| New | +$144K |
|
|
KEEL
306
Keel Infrastructure Corp
KEEL
$2.34B
| $160K | 0.02% |
+27,907
| New | +$120K |
|
307
indie Semiconductor
INDI
$854M
| $151K | 0.02% |
+33,680
| New | +$134K |
|
|
BNR
308
Burning Rock Biotech
BNR
$92.9M
| $136K | 0.02% |
+16,198
| New | +$229K |
|
309
Tenaya Therapeutics
TNYA
$163M
| $124K | 0.02% |
+168,200
| New | +$128K |
|
|
LX
310
LexinFintech Holdings
LX
$241M
| $97.6K | 0.01% |
+49,530
| New | +$105K |
|
311
Enovix
ENVX
$1.03B
| $71.7K | 0.01% |
+11,817
| New | +$78.3K |
|
312
Ambev
ABEV
$46.4B
| $62.8K | 0.01% |
+20,000
| New | +$62.5K |
|
|
NGEN
313
NervGen Pharma
NGEN
$182M
| $53K | 0.01% |
25,750
+4,825
| +23% | +$15K |
|
314
Archer Aviation
ACHR
$4.26B
| $49.3K | 0.01% |
10,420
-2,000
| -16% | -$11.6K |
|
|
BRR
315
ProCap Financial Inc
BRR
$160M
| $48.1K | 0.01% |
31,250
| – | – |
|
316
Voyager Therapeutics
VYGR
$201M
| $40.3K | 0.01% |
+11,500
| New | +$43.6K |
|
317
Recursion Pharmaceuticals
RXRX
$1.73B
| $39.3K | 0.01% |
+10,705
| New | +$35.6K |
|
318
Castellum
CTM
$58.3M
| $36K | ﹤0.01% |
50,000
| – | – |
|
|
ORBS
319
Eightco Holdings
ORBS
$267M
| $34.8K | ﹤0.01% |
+50,000
| New | +$45K |
|
|
PLG
320
Platinum Group Metals
PLG
$193M
| $14.2K | ﹤0.01% |
+10,500
| New | +$17.6K |
|
321
iQIYI
IQ
$1.28B
| $11.9K | ﹤0.01% |
+11,415
| New | +$13.3K |
|
322
Abbott
ABT
$187B
| – | – |
-2,830
| Closed | -$291K |
|
323
Accenture
ACN
$108B
| – | – |
-1,932
| Closed | -$383K |
|
324
Global X Artificial Intelligence & Technology ETF
AIQ
$10.2B
| – | – |
-18,781
| Closed | -$876K |
|
325
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| – | – |
-5,140
| Closed | -$471K |
|
Similar funds
MGAM
LSPW
JSL
NEAM
GCM
NCM
MO
TIS
Almanack Investment Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Almanack Investment Partners held 348 positions worth $785M, up 32% from $592M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Almanack Investment Partners deployed $158M of net new capital in Q2 2026, opening 171 new positions and adding to 90 existing holdings. Its largest new stake was iShares A.I. Innovation and Tech Active ETF: 307,265 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 2.6% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Schwab Emerging Markets Equity ETF, an estimated $12.3M trimmed.
- Almanack Investment Partners's largest Q2 2026 buy was iShares A.I. Innovation and Tech Active ETF: 307,265 shares worth $16.2M.
- Almanack Investment Partners added most to Alpha Architect 1-3 Month Box ETF in Q2 2026, an estimated $8.22M increase.
- Almanack Investment Partners's biggest Q2 2026 reduction was Schwab Emerging Markets Equity ETF, cutting an estimated $12.3M.
- Almanack Investment Partners fully exited State Street SPDR EURO STOXX 50 ETF in Q2 2026, selling an estimated $10.2M.
- Almanack Investment Partners's ten largest holdings make up 52% of its $785M portfolio in Q2 2026.
- Almanack Investment Partners opened 171 new positions and closed 27 in Q2 2026.
- Almanack Investment Partners's portfolio value rose 32% quarter-over-quarter to $785M.
Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.